Victor Perlroth M.D.
Net Worth
Last updated:
What is Victor Perlroth M.D. net worth?
The estimated net worth of Dr. Victor Perlroth M.D. is at least $35,837,395 as of 25 Feb 2022. He owns shares worth $20,249,475 as insider, has earned $12,257,920 from insider trading and has received compensation worth at least $3,330,000 in Kodiak Sciences Inc..
What is the salary of Victor Perlroth M.D.?
Dr. Victor Perlroth M.D. salary is $1,110,000 per year as Co-Founder, Chairman, Chief Executive Officer & Pres in Kodiak Sciences Inc..
How old is Victor Perlroth M.D.?
Dr. Victor Perlroth M.D. is 52 years old, born in 1973.
What stocks does Victor Perlroth M.D. currently own?
As insider, Dr. Victor Perlroth M.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | Co-Founder, Chairman, Chief Executive Officer & Pres | 2,168,038 | $9.34 | $20,249,475 |
What does Kodiak Sciences Inc. do?
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet inhibitor for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
Victor Perlroth M.D. insider trading
Kodiak Sciences Inc.
Dr. Victor Perlroth M.D. has made 2 insider trades in 2022, according to the Form 4 filled with the SEC. Most recently he sold 340,000 units of KOD stock worth $3,055,920 on 25 Feb 2022.
The largest trade he's ever made was exercising 1,000,000 units of KOD stock on 24 Feb 2022. As of 25 Feb 2022 he still owns at least 2,168,038 units of KOD stock.
Kodiak Sciences key executives
Kodiak Sciences Inc. executives and other stock owners filed with the SEC:
- Dr. Jason S. Ehrlich M.D., Ph.D. (49) Chief Medical Officer & Chief Devel. Officer
- Dr. Victor Perlroth M.D. (52) Co-Founder, Chairman, Chief Executive Officer & Pres
- Mr. John A. Borgeson CPA, M.B.A., MBA, CPA (63) Senior Vice President, Chief Financial Officer & Sec.